Convalescent Plasma Trial in COVID -19 Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 19, 2020

Primary Completion Date

June 15, 2020

Study Completion Date

July 9, 2020

Conditions
SARS-CoV 2COVID-19
Interventions
OTHER

plasma therapy using convalescent plasma with antibody against SARS-CoV-2

convalescent patient plasma plus routine local standard of care

OTHER

Routine care for COVID-19 patients

local standard of care which include antivirals and supportive care

Trial Locations (1)

Unknown

Royal College of Surgeons in Ireland - Bahrain, Manama

All Listed Sponsors
collaborator

Salmaniya Medical Complex

OTHER_GOV

collaborator

Bahrain Defence Force Hospital

OTHER

collaborator

Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali

UNKNOWN

lead

Royal College of Surgeons in Ireland - Medical University of Bahrain

OTHER

NCT04356534 - Convalescent Plasma Trial in COVID -19 Patients | Biotech Hunter | Biotech Hunter